| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT05846516 A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With… |
Trial sites reduced: 24 -> 20 locations |
| 2026-06-10 | NCT05846516 A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With… |
date change Primary completion moved earlier: 2027-06-27 -> 2027-03-08 |
| 2026-06-10 | NCT05846516 A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With… |
date change Completion moved earlier: 2027-06-27 -> 2027-03-08 |
| 2026-06-05 | NCT07395258 A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1… |
Recruitment suspended |
| 2026-06-05 | NCT07395258 A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1… |
critical why stopped: null → "Temporary enrolment hold as a precautionary measure following a safety event in a related trial" |
| 2026-06-05 | NCT07395258 A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1… |
Trial sites reduced: 10 -> 1 locations |
| 2026-05-28 | NCT05068102 A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With… |
date change Primary completion pushed: 2026-05-29 -> 2026-09-16 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-26 | NCT07607678 A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are… | Phase 1 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT03383978 | Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab… | Glioblastoma | Recruiting |
| NCT07607678 | A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are… | Advanced Solid Cancer | Recruiting |
| NCT05879978 | A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With… | Small Cell Lung Carcinoma (SCLC) | Active, Not Recruiting |
| NCT04958239 | A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With… | Neoplasms | Active, Not Recruiting |
| NCT05068102 | A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With… | Carcinoma, Squamous Cell of Head and Neck (HNSCC) | Active, Not Recruiting |
| NCT05249426 | A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy… | Head and Neck Squamous Cell Carcinoma (HNSCC) | Active, Not Recruiting |
| NCT05846516 | A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting |